Severe childhood speech disorder: Gene discovery highlights transcriptional dysregulation.
Michael S HildebrandVictoria E JacksonThomas S ScerriOlivia Van ReykMatthew J ColemanRuth O BradenSamantha TurnerKristin A RigbyeAmber BoysSarah BartonRichard WebsterMichael FaheyKerryn SaundersBronwyn Parry-FielderGeorgia PaxtonMichael HaymanDavid ComanHimanshu GoelAnne BaxterAlan MaNoni DavisSheena ReillyMartin DelatyckiFrederique J LiégeoisAlan ConnellyJozef GeczSimon E FisherDavid J AmorIngrid E SchefferMelanie BahloAngela T MorganPublished in: Neurology (2020)
We identify the likely genetic etiology in 11 patients with CAS and implicate 9 genes for the first time. We find that CAS is often a sporadic monogenic disorder, and highly genetically heterogeneous. Highly penetrant variants implicate shared pathways in broad transcriptional regulation, highlighting the key role of transcriptional regulation in normal speech development. CAS is a distinctive, socially debilitating clinical disorder, and understanding its molecular basis is the first step towards identifying precision medicine approaches.